1. Home
  2. CCB vs COLL Comparison

CCB vs COLL Comparison

Compare CCB & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$74.19

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.42

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
COLL
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
CCB
COLL
Price
$74.19
$32.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$126.67
$51.17
AVG Volume (30 Days)
133.3K
547.7K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.06
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$96.61
$5.93
Revenue Next Year
$22.66
N/A
P/E Ratio
$24.43
$19.32
Revenue Growth
N/A
23.62
52 Week Low
$70.72
$23.23
52 Week High
$120.05
$50.79

Technical Indicators

Market Signals
Indicator
CCB
COLL
Relative Strength Index (RSI) 35.92 24.32
Support Level $70.72 $31.01
Resistance Level $118.72 $32.92
Average True Range (ATR) 2.60 1.30
MACD 0.52 -0.04
Stochastic Oscillator 5.08 1.07

Price Performance

Historical Comparison
CCB
COLL

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: